ArticleEye (London, England)2026
Infographic: a randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patients.
Erind Alushaj et al.PubMed ↗Publisher ↗
No numbers read from the abstract.